502 related articles for article (PubMed ID: 24372179)
1. Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.
Miró J; Aiguabella M; Veciana M; Juvany R; Santurino M; Leiva E; Salas-Puig J; Falip M
Acta Neurol Scand; 2014 May; 129(5):e20-3. PubMed ID: 24372179
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
[TBL] [Abstract][Full Text] [Related]
3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
[TBL] [Abstract][Full Text] [Related]
5. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
6. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate.
Calleja S; Salas-Puig J; Ribacoba R; Lahoz CH
Seizure; 2001 Sep; 10(6):424-7. PubMed ID: 11700996
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
[TBL] [Abstract][Full Text] [Related]
8. High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.
Hernández-Vanegas LE; Jara-Prado A; Ochoa A; Rodríguez Y Rodríguez N; Durón RM; Crail-Meléndez D; Alonso ME; Delgado-Escueta AV; Martínez-Juárez IE
Epilepsy Behav; 2016 Aug; 61():34-40. PubMed ID: 27300146
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
[TBL] [Abstract][Full Text] [Related]
10. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies.
Gelisse P; Genton P; Kuate C; Pesenti A; Baldy-Moulinier M; Crespel A
Epilepsia; 2004 Oct; 45(10):1282-6. PubMed ID: 15461683
[TBL] [Abstract][Full Text] [Related]
11. Low dose sodium valproate in the treatment of juvenile myoclonic epilepsy.
Karlovassitou-Koniari A; Alexiou D; Angelopoulos P; Armentsoudis P; Dimitrakoudi E; Delithanasis I; Hamlatzis P; Baloyannis S
J Neurol; 2002 Apr; 249(4):396-9. PubMed ID: 11967642
[TBL] [Abstract][Full Text] [Related]
12. Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China.
Wang L; Jiang Z; Chen BB; Wang CT; Wang JX; Bai J; Wang B; Jin L; Zhang WJ; Deng YC; Zhao G; Dang JX; Wang D; Jia SS; Wang TC; Jia FY; Zhang L; Liu YH
Epilepsy Behav; 2016 Sep; 62():204-8. PubMed ID: 27494356
[TBL] [Abstract][Full Text] [Related]
13. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
Montouris G; Abou-Khalil B
Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
Chowdhury A; Brodie MJ
Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
[TBL] [Abstract][Full Text] [Related]
15. Seizure outcome in 175 patients with juvenile myoclonic epilepsy--a long-term observational study.
Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
Epilepsy Res; 2014 Dec; 108(10):1817-24. PubMed ID: 25443450
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic epilepsy with generalized tonic-clonic seizures only versus idiopathic epilepsy with phantom absences and generalized tonic-clonic seizures: one or two syndromes?
Koutroumanidis M; Aggelakis K; Panayiotopoulos CP
Epilepsia; 2008 Dec; 49(12):2050-62. PubMed ID: 18616555
[TBL] [Abstract][Full Text] [Related]
17. [Juvenile myoclonic epilepsy--an underdiagnosed epileptic syndrome].
Shahar E; Ravid S
Harefuah; 1996 Nov; 131(9):313-8, 375. PubMed ID: 8981799
[TBL] [Abstract][Full Text] [Related]
18. Outcome of lamotrigine treatment in juvenile myoclonic epilepsy.
Bodenstein-Sachar H; Gandelman-Marton R; Ben-Zeev B; Chapman J; Blatt I
Acta Neurol Scand; 2011 Jul; 124(1):22-7. PubMed ID: 21208196
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial.
Tabrizi N; Zarvani A; Rezaei P; Cheraghmakani H; Alizadeh-Navaei R
Epilepsy Res; 2019 Nov; 157():106214. PubMed ID: 31627041
[TBL] [Abstract][Full Text] [Related]
20. [Juvenile myoclonic epilepsy].
Ercegovac MD; Vojvodić N; SokićDV ; Janković SM; Drulović J; Stojsavljević N; Lević Z
Srp Arh Celok Lek; 1998; 126(9-10):335-44. PubMed ID: 9863404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
